Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

The Ocular Hypertension Treatment Study (OHTS): Longitudinal analyses of mean deviation (MD) loss and its association with visual acuity (VA) and contrast sensitivity (CS) in eyes newly diagnosed with primary-open angle glaucoma (POAG)

Mae O Gordon; J Phiilip Miller; Julia Beiser; Michael A Kass; Feng Gao; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5647.

ARVO Annual Meeting Abstract June 2013

The Ocular Hypertension Treatment Study (OHTS): Does Higher Long-Term IOP Variability Increase Risk Of Developing Primary Open Angle Glaucoma (POAG) in the Medication Group?

Mae Gordon; Julia Beiser; J. Phillip Miller; Michael Kass; Feng Gao; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3506.

ARVO Annual Meeting Abstract June 2013

Computational discovery of optic nerve head phenotypes

Mark Christopher; Li Tang; John Fingert; Todd Scheetz; Michael Abramoff; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4819.

Glaucoma February 2013

Series Length Used during Trend Analysis Affects Sensitivity to Changes in Progression Rate in the Ocular Hypertension Treatment Study

PDF

Stuart K. Gardiner; Shaban Demirel; Carlos Gustavo De Moraes; Jeffrey M. Liebmann; George A. Cioffi; Robert Ritch; Mae O. Gordon; Michael A. Kass; for the Ocular Hypertension Treatment Study Group
TAGS: eye, ocular hypertension, trend, universities, ophthalmology
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1252-1259. https://doi.org/10.1167/iovs.12-10218

Clinical Trials April 2012

Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group

PDF

Carlos Gustavo De Moraes; Shaban Demirel; Stuart K. Gardiner; Jeffrey M. Liebmann; George A. Cioffi; Robert Ritch; Mae O. Gordon; Michael A. Kass; For the Ocular Hypertension Treatment Study Group
TAGS: eye, ocular hypertension, open-angle glaucoma, velocity, visual fields
Invest. Ophthalmol. Vis. Sci.. 2012; 53(4):1704-1709. https://doi.org/10.1167/iovs.11-8186

ARVO Annual Meeting Abstract March 2012

Seasonal Variations in Sensitivity and Intraocular Pressure (IOP) in the Ocular Hypertension Treatment Study (OHTS)

Stuart K. Gardiner; Shaban Demirel; Mae O. Gordon; Michael A. Kass; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1751.

Clinical Trials January 2012

The Rate of Visual Field Change in the Ocular Hypertension Treatment Study

PDF

Shaban Demirel; Carlos Gustavo V. De Moraes; Stuart K. Gardiner; Jeffrey M. Liebmann; George A. Cioffi; Robert Ritch; Mae O. Gordon; Michael A. Kass; for the Ocular Hypertension Treatment Study
TAGS: eye, ocular hypertension, open-angle glaucoma, visual fields, optic disk
Invest. Ophthalmol. Vis. Sci.. 2012; 53(1):224-227. https://doi.org/10.1167/iovs.10-7117

ARVO Annual Meeting Abstract April 2011

Does Greater Long-term Intraocular Pressure (IOP) Variability Increase Probability Of Developing Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatement Study (OHTS)?

Mae O. Gordon; Julia A. Beiser; J. Phillip Miller; Michael Kass; Feng Gao; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3442.

ARVO Annual Meeting Abstract April 2011

Rates of Visual Field Change in Eyes with Optic Disc Hemorrhage in the Ocular Hypertension Treatment Study

Shaban Demirel; Gustavo V. De Moraes; Stuart K. Gardiner; Jeffrey M. Liebmann; George A. Cioffi; Robert Ritch; Mae O. Gordon; Michael A. Kass; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2119.

ARVO Annual Meeting Abstract April 2010

Impact of Attributing Cause of Abnormality to POAG on Endpoint Rate and Statistical Power in the Ocular Hypertension Treatment Study

M. O. Gordon; D. K. Heuer; E. J. Higginbotham; R. K. Parrish, II; P. A. Morris; D. A. Dunn; B. S. Wilson; M. A. Kass; The Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):204.

ARVO Annual Meeting Abstract April 2010

Effect of Treatment on Rates of Visual Field Change in the Ocular Hypertension Treatment Study

C. G. De Moraes; S. Demirel; S. K. Gardiner; J. M. Liebmann; G. A. Cioffi; R. Ritch; M. O. Gordon; M. A. Kass; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2049.

ARVO Annual Meeting Abstract April 2010

Does Adjusting IOP for Central Corneal Thickness Improve Accuracy of the Prediction Model for the Development of POAG?

J. D. Brandt; M. O. Gordon; M. A. Kass; J. A. Beiser; F. Gao; Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2708.

ARVO Annual Meeting Abstract April 2010

Rates of Change of Mean Deviation in the Ocular Hypertension Treatment Study

S. Demirel; C. G. de Moraes; S. K. Gardiner; J. M. Liebmann; G. A. Cioffi; R. Ritch; M. O. Gordon; M. A. Kass; Ocular Hypertension Treatment Study

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5520.

ARVO Annual Meeting Abstract April 2009

Quantitating the Impact of Clinical and Basic Science Research

M. E. Gordon; C. Sarli; E. K. Dubinsky; E. Long; C. LaRue; M. A. Kass; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2469.

ARVO Annual Meeting Abstract May 2008

Intraocular Pressure Variability in Observation Participants in the Ocular Hypertension Treatment Study (OHTS)

A. M. Bhorade; B. S. Wilson; P. Palmberg; E. Miller; R. Weinreb; M. A. Kass; M. O. Gordon; The Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2048.

ARVO Annual Meeting Abstract May 2008

The 20-Year Incidence of Primary Open Angle Glaucoma Among People With Ocular Hypertension---A Decision Analytic Approach

S. M. Kymes; M. A. Kass; J. P. Miller; M. O. Gordon; the Ocular Hypertension Treatment Study group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5055.

ARVO Annual Meeting Abstract May 2008

Retinal Vein Occlusions (RVO) in the Ocular Hypertension Treatment Study (OHTS)

E. M. Barnett; A. Fantin; B. S. Wilson; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5463.

ARVO Annual Meeting Abstract May 2008

Application of Brusini’s Glaucoma Staging System 2 (GSS 2) to Glaucomatous Visual Fields in the Ocular Hypertension Treatment Study (OHTS)

J. L. Keltner; C. A. Johnson; K. E. Cello; P. Brusini; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1102.

ARVO Annual Meeting Abstract May 2007

Comparison of Prediction Models for POAG Using Means of Both Eyes, Asymmetry Between Eyes and the Worse Eye

M. E. Gordon; Ocular Hypertension Treatment Study/European Glaucoma Prevention Study

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):857.

ARVO Annual Meeting Abstract May 2007

A Comparison of Full Threshold and Swedish Interactive Threshold Algorithms (SITA) Testing Procedures in the Ocular Hypertension Treatment Study (OHTS)

S. E. Bandermann; J. L. Keltner; C. A. Johnson; K. E. Cello; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1643.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Ocular Hypertension Treatment Study (OHTS): Longitudinal analyses of mean deviation (MD) loss and its association with visual acuity (VA) and contrast sensitivity (CS) in eyes newly diagnosed with primary-open angle glaucoma (POAG)

The Ocular Hypertension Treatment Study (OHTS): Does Higher Long-Term IOP Variability Increase Risk Of Developing Primary Open Angle Glaucoma (POAG) in the Medication Group?

Computational discovery of optic nerve head phenotypes

Series Length Used during Trend Analysis Affects Sensitivity to Changes in Progression Rate in the Ocular Hypertension Treatment Study

Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group

Seasonal Variations in Sensitivity and Intraocular Pressure (IOP) in the Ocular Hypertension Treatment Study (OHTS)

The Rate of Visual Field Change in the Ocular Hypertension Treatment Study

Does Greater Long-term Intraocular Pressure (IOP) Variability Increase Probability Of Developing Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatement Study (OHTS)?

Rates of Visual Field Change in Eyes with Optic Disc Hemorrhage in the Ocular Hypertension Treatment Study

Impact of Attributing Cause of Abnormality to POAG on Endpoint Rate and Statistical Power in the Ocular Hypertension Treatment Study

Effect of Treatment on Rates of Visual Field Change in the Ocular Hypertension Treatment Study

Does Adjusting IOP for Central Corneal Thickness Improve Accuracy of the Prediction Model for the Development of POAG?

Rates of Change of Mean Deviation in the Ocular Hypertension Treatment Study

Quantitating the Impact of Clinical and Basic Science Research

Intraocular Pressure Variability in Observation Participants in the Ocular Hypertension Treatment Study (OHTS)

The 20-Year Incidence of Primary Open Angle Glaucoma Among People With Ocular Hypertension---A Decision Analytic Approach

Retinal Vein Occlusions (RVO) in the Ocular Hypertension Treatment Study (OHTS)

Application of Brusini’s Glaucoma Staging System 2 (GSS 2) to Glaucomatous Visual Fields in the Ocular Hypertension Treatment Study (OHTS)

Comparison of Prediction Models for POAG Using Means of Both Eyes, Asymmetry Between Eyes and the Worse Eye

A Comparison of Full Threshold and Swedish Interactive Threshold Algorithms (SITA) Testing Procedures in the Ocular Hypertension Treatment Study (OHTS)

To View More...

You must be signed into an individual account to use this feature.